HHS Grants Liability Protection to Pandemic Vaccine Manufacturers

Manufacturers of vaccines used to prevent potential avian pandemics will receive immunity from product liability claims, HHS announced on January 1.

The move, which triggers a provision of the Public Readiness and Emergency Preparedness Act passed in late 2005, would grant protection from such claims for parties involved in the preparation of reference strains and the development, manufacturing, testing, and administration of vaccines.